Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors
Yongqiang Liu(Ningbo University), Guang‐Biao Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 65
Related Papers
Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer
|Carcinogenesis|2013|105
Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition
|Nature Communications|2019|68